• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Adline Chem Lab Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5655.0
  • ISIN : INE276T01018
12.12 0 (0.00%)
  • As on 04 Sep 2026 (EOD)

  • Today’s Low

    12.12

  • Today’s High

    12.12

  • Open

    12.12

  • Perv Close

    12.12

  • 52W Low

    7.60

  • 52W High

    17.06

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    7.09

  • Div & Yield %

    0.00

  • Book Value(₹)

    -3.03

  • Debt-Equity Ratio

    0.00

  • AGM Date

    03-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    7.09

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.85

  • BV (₹)

    -3.00

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -0.28

  • NP Var(%)

    -113.0

  • Div%

    0.0

  • CPS (₹)

    -0.50

  • EPS (₹)

    -0.50

  • Traded Value (₹ in Lakhs)

    7.09

  • 52 Week High

    17.06

  • 52 Week Low

    7.60

  • Price BSE

    12.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    7.09

  • P/C Ratio

    -25.00

  • P/E Ratio

    -25.00

  • Price Vs.BV

    -0.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.74 6.33 6.59
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.74 6.33 6.59
Other Income 0.25 0.00 1.00 1.33 0.00 8.21
Stock Adjustments 0.00 0.00 -0.26 -0.13 -0.70 -1.63
Total Income 0.25 0.00 0.74 1.94 5.63 13.17
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.35 2.33 3.25
Power and Fuel Cost 0.00 0.00 0.00 0.01 0.03 0.07
Employee Cost 0.18 0.04 0.05 0.18 1.71 1.94
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.10 0.34
Selling and Administration Expenses 0.11 0.13 0.07 0.23 1.08 1.19
Miscellaneous Expenses 0.00 0.01 4.76 0.12 0.60 9.44
Employee Benefit Expenses 0.18 0.04 0.05 0.18 1.71 1.94
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.29 0.18 4.88 0.90 5.86 16.24
Operating Profit -0.05 -0.18 -4.15 1.03 -0.23 -3.06
Interest 0.16 0.12 0.00 0.01 0.03 0.02
Gross Profit -0.21 -0.30 -4.15 1.02 -0.26 -3.08
Depreciation 0.00 0.00 0.09 0.35 1.02 0.42
Profit Before Tax -0.21 -0.30 -4.24 0.67 -1.28 -3.50
Current Tax -0.10 0.00 0.00 0.00 0.00 0.26
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.03 -0.03 0.00 -0.05 0.00 0.00
Reported Net Profit -0.13 -0.27 -4.23 0.72 -1.28 -3.76
Extraordinary Items 0.00 0.00 -4.35 1.14 0.00 0.22
Adjusted Net Profit -0.13 -0.27 0.12 -0.42 -1.28 -3.98
Adjustment below Net Profit 0.01 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -7.89 -7.62 -3.38 -4.10 -2.82 0.95
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -8.01 -7.89 -7.62 -3.38 -4.10 -2.82
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.23 -0.46 -7.24 1.23 -2.19 -6.44
Earnings Per Share(Adj)-Unit Curr -0.23 - -7.24 1.23 -2.19 -6.44
Book Value -2.55 -2.35 -2.68 4.53 3.30 5.49
Book Value(Adj)-Unit Curr -2.55 - -2.68 4.53 3.30 5.49

Shareholding Pattern

  • Promoter Group

    25.85%

  • Public Share Holding

    74.15%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,512,440 25.85 1,512,440 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,512,440 25.85 1,512,440 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 28,510 0.49 8,800 14
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 575,850 9.84 9,450 946
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 900 0.02 900 6
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 483,800 8.27 41,300 9
Individuals holding nominal share capital up to Rs. 1 lakh 3,243,500 55.44 298,500 17,467
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,337,560 74.15 363,950 18,443
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,850,000 100.00 1,876,390 18,444

Company Background

Adline Chem Lab LtdPharmaceuticals - Indian - Formulations

  • Adline Chem Lab Ltd
  • BSE Code : 5655.0
  • ISIN : INE276T01018

  • Incorporation Year

    1988

  • Registered Office

    A-514 Steller Opp Arista Bldg
    Sindhu bhavan Road Bodakdev, Ahmedabad,
    Gujarat-380054

  • Telephone

  • FAX

  • Chairman

    Vrushank Balkrushna Patel

  • Managing Director

    Vrushank Balkrushna Patel

  • Company Secretary

    Ritu Singh

  • Auditor

    Deepak Soni & Associates/Jain Kedia & Sharma

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-1 Off C.G Road ,Ellisbridge
    Mumbai - Ahmedabad-380006

Adline Chem Lab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Adline Chem Lab 12.12 0.25 0.00 -37.88 0.00
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77